D&DIAGNOSIS & EARLY DETECTION
Diagnosis & Early Detection/August 10, 2026/2 min read

New Study Links Blood Cell Patterns to Insulin Resistance in Type 1 Diabetes

Researchers in India found that certain white blood cells and other blood components may reflect whether someone with Type 1 diabetes is developing reduced insulin sensitivity. The findings could eventually help identify who is at risk for complications.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

  • A small group of people with Type 1 diabetes develop reduced insulin sensitivity—sometimes called 'double diabetes'—which increases complication risk
  • Blood cell counts show patterns that may correlate with insulin sensitivity levels in children and young adults with Type 1 diabetes
  • Eosinophils (a type of white blood cell) showed a positive link to insulin sensitivity, while other blood cells like neutrophils and lymphocytes showed negative associations
  • These associations varied depending on age, sex, and BMI, suggesting blood cell patterns are complex and individual
  • This is early research that may eventually help identify which people with Type 1 diabetes need closer monitoring, but much more work is needed

What Is Double Diabetes?

Most people with Type 1 diabetes need insulin injections or pumps to survive because their immune system has attacked the cells that make insulin. But a subset of people with Type 1 diabetes also develop insulin resistance—meaning their bodies don't respond well to insulin, even when they're getting it.

This combination is sometimes called 'double diabetes.' It's not the same as Type 2 diabetes, but it does create extra challenges: people need more insulin, face higher risks of heart disease and kidney damage, and often struggle harder to reach their blood sugar targets. The reason why some people develop this complication remains unclear.

How Researchers Looked at Blood Cells

Scientists at a hospital in western India studied 343 children and young adults with Type 1 diabetes to explore whether changes in blood cell counts might signal reduced insulin sensitivity.

They measured different types of blood cells—including lymphocytes, neutrophils, monocytes, eosinophils, and platelets—and calculated an estimated insulin sensitivity score using a validated formula. Then they looked for connections between cell counts and insulin sensitivity across different age groups, sexes, and weight categories.

What the Study Found

Certain blood cell patterns showed links to insulin sensitivity, though most associations were modest. Eosinophils (infection-fighting white blood cells) consistently showed a positive relationship with better insulin sensitivity across all age, sex, and weight groups.

Other cells—including monocytes, neutrophils, lymphocytes, and platelets—tended to show negative associations with insulin sensitivity, though these patterns varied by subgroup. When looking at the whole group, neutrophils and lymphocytes showed statistically significant but very small negative relationships.

What This Means and What's Still Unknown

This study suggests that blood cell counts might act as biological markers—visible signs that something is changing in the body. If confirmed in larger studies, doctors might one day use simple blood tests to identify which people with Type 1 diabetes are at higher risk for developing insulin resistance.

However, this is early-stage research. The associations were small, patterns differed across different groups of people, and the researchers haven't yet explained *why* these blood cell changes occur or what they mean for treatment. Much more work is needed before these findings could guide clinical care.

Evidence label

Source: Endocrine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.